Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1967 Aug 1;126(2):189-206.
doi: 10.1084/jem.126.2.189.

A plasmin-split fragment of C'3 as a new chemotactic factor

A plasmin-split fragment of C'3 as a new chemotactic factor

P A Ward. J Exp Med. .

Abstract

When streptokinase and highly purified human plasminogen are added to human serum or to partly purified or highly purified preparations containing the third component of complement (C'3), either rabbit or human, a chemotactic factor is generated. This chemotactic factor is a split product of C'3 and is dialyzable, fast moving electrophoretically, slowly sedimenting in sucrose density gradient ultracentrifugation, and has an approximate molecular weight of 6000. It is calculated that this fragment accounts for approximately 4% of the intact molecule. The C'3 fragment has the following biologic properties: It is chemotactic for rabbit PMN's in vitro, it causes accumulation of PMN's in vivo, and it increases vascular permeability in rat skin. In addition to generating a chemotactic factor, plasmin destroys the complement-associated chemotactic factor that is a trimolecular complex consisting of the fifth (C'5), sixth (C'6), and seventh (C'7) components of complement. This has been shown by a loss of chemotactic activity, as well as a dissociation of the C'5, C'6, C'7 complex and a destruction of C'6 hemolytic activity. The biologic significance of the plasmin-generated chemotactic factor is discussed in relation to other recently discovered biologically active fragments of C'3.

PubMed Disclaimer

References

    1. J Immunol. 1965 Jun;94:877-82 - PubMed
    1. J Exp Med. 1965 Aug 1;122:277-98 - PubMed
    1. J Exp Med. 1967 Jul 1;126(1):149-58 - PubMed
    1. J Immunol. 1963 May;90:751-9 - PubMed
    1. Biochem J. 1965 Sep;96(3):595-606 - PubMed